3148: AI Meets Pharma: How BioPhy is Accelerating Clinical Trials
Can artificial intelligence redefine the future of drug development and clinical trials? In this episode of Tech Talks Daily, I sit down with Dave Latshaw, Ph.D., the internationally recognized AI and machine learning expert who serves as CEO of BioPhy. Founded in 2019, BioPhy focuses on using AI to revolutionize the later stages of drug development, a critical yet often overlooked segment of the pharmaceutical pipeline. Dave shares insights into BioPhy's innovative platform, which combines scientific, clinical, and regulatory insights to predict clinical trial success and steer capital…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.